NYSE : ALC
Alcon Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · Switzerland
Last price 71.45 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 34.68B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 36.76B |
| Enterprise Value | 40.55B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | May 6, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 483.40M |
| Shares Outstanding | 483.40M |
| Shares Change (YoY) | -1.24% |
| Shares Change (QoQ) | -0.31% |
| Owned by Insiders (%) | 0.17% |
| Owned by Institutions (%) | 56.97% |
| Float | 481.84M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 56.88 |
| Forward PE | 19.80 |
| PS Ratio | 3.28 |
| Forward PS | 3.04 |
| PB Ratio | 1.65 |
| P/TBV Ratio | 8.77 |
| P/FCF Ratio | 20.49 |
| P/OCF Ratio | 15.43 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 61.34 |
| EV / Sales | 3.63 |
| EV / EBITDA | 16.41 |
| EV / EBIT | 28.19 |
| EV / FCF | 22.67 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.09 |
| Quick Ratio | 1.12 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 2.12 |
| Debt / FCF | 3.05 |
| Interest Coverage | 6.69 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 2.94% |
| Return on Assets (ROA) | 2.80% |
| Return on Invested Capital (ROIC) | 4.75% |
| Return on Capital Employed (ROCE) | 5.01% |
| Weighted Average Cost of Capital (WACC) | 7.62% |
| Revenue Per Employee | $434,440 |
| Profits Per Employee | $25,720 |
| Employee Count | 25,000 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 1.89 |
Taxes
| Measure | Value |
|---|
| Income Tax | 98.00M |
| Effective Tax Rate | 13.23% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.73 |
| 52-Week Price Change | +0.03% |
| 50-Day Moving Average | 67.65 |
| 200-Day Moving Average | 71.92 |
| Relative Strength Index (RSI) | 73.85 |
| Average Volume (20 Days) | 1,584,965 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 19.55M |
| Short Previous Month | 17.49M |
| Short % of Shares Out | 1.52% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 10.62 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 10.86B |
| Gross Profit | 6.22B |
| Operating Income | 1.40B |
| Pretax Income | 741.00M |
| Net Income | 643.00M |
| EBITDA | 2.40B |
| EBIT | 1.40B |
| Earnings Per Share (EPS) | $1.30 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.46B |
| Total Debt | 5.30B |
| Net Cash | -3.84B |
| Net Cash Per Share | -$7.95 |
| Equity (Book Value) | 21.60B |
| Book Value Per Share | 44.67 |
| Working Capital | 3.46B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 2.31B |
| Capital Expenditures | -570.00M |
| Depreciation & Amortization | 1.01B |
| Net Borrowing | -86.00M |
| Free Cash Flow | 1.74B |
| FCF Per Share | $3.60 |
Margins
| Measure | Value |
|---|
| Gross Margin | 57.22% |
| Operating Margin | 12.88% |
| Pretax Margin | 6.82% |
| Profit Margin | 5.92% |
| EBITDA Margin | 22.13% |
| EBIT Margin | 12.88% |
| FCF Margin | 16.02% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $0.23 |
| Dividend Yield | 0.31% |
| Dividend Growth (YoY) | 7.61% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 18.14% |
| FCF Payout Ratio | 6.47% |
| Buyback Yield | 1.24% |
| Shareholder Yield | 1.55% |
| Earnings Yield | 1.76% |
| FCF Yield | 4.88% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $81.98 |
| Price Target Difference | 11.27% |
| Analyst Consensus | Buy |
| Analyst Count | 27 |
| Revenue Growth Forecast (3Y) | 6.31% |
| EPS Growth Forecast (3Y) | 13.64% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |